chr19-8066028-C-T
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 2P and 12B. PM2BP4_StrongBP6_Very_Strong
The NM_032447.5(FBN3):c.8321G>A(p.Arg2774Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000688 in 1,613,110 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R2774W) has been classified as Uncertain significance.
Frequency
Consequence
NM_032447.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -10 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
FBN3 | NM_032447.5 | c.8321G>A | p.Arg2774Gln | missense_variant | 64/64 | ENST00000600128.6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
FBN3 | ENST00000600128.6 | c.8321G>A | p.Arg2774Gln | missense_variant | 64/64 | 1 | NM_032447.5 | ||
FBN3 | ENST00000270509.6 | c.8321G>A | p.Arg2774Gln | missense_variant | 63/63 | 1 | |||
FBN3 | ENST00000601739.5 | c.8321G>A | p.Arg2774Gln | missense_variant | 64/64 | 1 | |||
FBN3 | ENST00000651877.1 | c.8447G>A | p.Arg2816Gln | missense_variant | 64/64 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000256 AC: 39AN: 152250Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000683 AC: 17AN: 248832Hom.: 0 AF XY: 0.0000444 AC XY: 6AN XY: 135116
GnomAD4 exome AF: 0.0000493 AC: 72AN: 1460742Hom.: 0 Cov.: 31 AF XY: 0.0000427 AC XY: 31AN XY: 726684
GnomAD4 genome AF: 0.000256 AC: 39AN: 152368Hom.: 0 Cov.: 33 AF XY: 0.000188 AC XY: 14AN XY: 74506
ClinVar
Submissions by phenotype
not provided Benign:2
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 07, 2019 | - - |
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 28, 2022 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
See cases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Laboratorio de Genetica e Diagnostico Molecular, Hospital Israelita Albert Einstein | Dec 15, 2019 | ACMG classification criteria: PM2, BP1, BP4 - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at